Fikriye Tuter Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fikriye Tuter Yilmaz has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Tokuc
Department of Gastroenterology, Kepez State Hospital
1 shared publication - Ayse Ayan
Department of Rheumatology, Antalya Training and Research Hospital, University of Health Sciences, Antalya 07100, Turkey
1 shared publication - Ayça İnCi
Division of Nephrology, Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Türkiye
1 shared publication Ebru Barçin
School of Medicine, Department of Neurology, Akdeniz University, Pınarbaşı Mahallesi, Akdeniz Üniversitesi Kampüsü, 07070, Antalya, Turkey
1 shared publication- Fikriye Tüter Yilmaz
Department of Neurology, Antalya Training and Research Hospital, Varlık Mahallesi Kazım Karabekir Caddesi Soğuksu, 07100, Antalya, Turkey.
1 shared publication - Gulay Demirtas
Department of Nephrology University of Health Sciences, Antalya Training and Research Hospital Antalya Turkey
1 shared publication
Latest Publications
- Open Access
- 13 May 2022
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 66 (3) , 295-302
Capillaroscopic appearance of nailfold vasculature of diabetic nephropathy patients
Objectives: Diabetic nephropathy is a microvascular complication of diabetes and the most common cause of end-stage renal failure throughout the world. Videocapillaroscopy is a simple and noninvasive method that can display capillaries in the nail bed at the micron level. A few studies have been conducted on detecting retinopathy, another important diabetic microvascular complication, with videocapillaroscopy; however, no comprehensive study has been performed on diabetic nephropathy. We aimed to determine the relationship between nephropathy and capillaroscopic changes. Subjects and [...] ABSTRACT Objectives: Diabetic nephropathy is a microvascular complication of diabetes and the most common cause of end-stage renal failure throughout the world. Videocapillaroscopy is a simple and noninvasive method that can display capillaries in the nail bed at the micron level. A few studies have been conducted on detecting retinopathy, another important diabetic microvascular complication, with videocapillaroscopy; however, no comprehensive study has been performed on diabetic nephropathy. We aimed to determine the relationship between nephropathy and capillaroscopic changes. Subjects and
- 13 May 2022
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 66 (3) , 295-302
Open AccessCapillaroscopic appearance of nailfold vasculature of diabetic nephropathy patients
Objectives: Diabetic nephropathy is a microvascular complication of diabetes and the most common cause of end-stage renal failure throughout the world. Videocapillaroscopy is a simple and noninvasive method that can display capillaries in the nail bed at the micron level. A few studies have been conducted on detecting retinopathy, another important diabetic microvascular complication, with videocapillaroscopy; however, no comprehensive study has been performed on diabetic nephropathy. We aimed to determine the relationship between nephropathy and capillaroscopic changes. Subjects and [...] ABSTRACT Objectives: Diabetic nephropathy is a microvascular complication of diabetes and the most common cause of end-stage renal failure throughout the world. Videocapillaroscopy is a simple and noninvasive method that can display capillaries in the nail bed at the micron level. A few studies have been conducted on detecting retinopathy, another important diabetic microvascular complication, with videocapillaroscopy; however, no comprehensive study has been performed on diabetic nephropathy. We aimed to determine the relationship between nephropathy and capillaroscopic changes. Subjects and
- 8 September 2017
- Published by Springer Nature in Neurological Sciences
- Vol. 38 (12) , 2103-2109
Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson’s disease
Abnormalities in auditory P300 test have been observed in patients with Parkinson’s disease (PD). We aimed to investigate whether or not additional electrophysiological tests assist in making the clinical diagnosis of mild cognitive impairment in Parkinson’s disease (PD-MCI), and we evaluated P300 changes in patients with non-demented PD and analyzed the correlation between the cognitive features and P300 changes. Twenty patients with PD who had been diagnosed with mild cognitive impairment (PD-MCI group) according to the Movement Disorder Society (MDS) 2012 PD-MCI level II criteria, 21 patients with PD without cognitive impairment (PD-Normal group), and 20 control subjects (control group) who were neurologically normal were examined by the standard auditory oddball paradigm. The N100, P200, N200, and P300 latencies and N100-P200, P200-N200, and N200-P300 amplitudes were measured and analyzed. P300 latencies recorded from Fz, Cz, and Pz and N200 latency recorded from Fz were significantly longer in the PD-MCI group than in the PD-Normal and the control group (respectively p < 0.001, p = 0.041). P300 amplitude recorded from Fz was significantly lower in PD-MCI group than those in the other groups (p = 0.038). While P300 was obtained in all patients in the PD-Normal and the control group, it was lost in 35% of PD-MCI patients. The results show that P300 provides a diagnostic tool for detecting PDMCI. We suggest that P300 prolongation and loss of P300 potential could be used as supportive parameter in the diagnosis of PD-MCI.
- 8 September 2017
- Published by Springer Nature in Neurological Sciences
- Vol. 38 (12) , 2103-2109
Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson’s disease
Abnormalities in auditory P300 test have been observed in patients with Parkinson’s disease (PD). We aimed to investigate whether or not additional electrophysiological tests assist in making the clinical diagnosis of mild cognitive impairment in Parkinson’s disease (PD-MCI), and we evaluated P300 changes in patients with non-demented PD and analyzed the correlation between the cognitive features and P300 changes. Twenty patients with PD who had been diagnosed with mild cognitive impairment (PD-MCI group) according to the Movement Disorder Society (MDS) 2012 PD-MCI level II criteria, 21 patients with PD without cognitive impairment (PD-Normal group), and 20 control subjects (control group) who were neurologically normal were examined by the standard auditory oddball paradigm. The N100, P200, N200, and P300 latencies and N100-P200, P200-N200, and N200-P300 amplitudes were measured and analyzed. P300 latencies recorded from Fz, Cz, and Pz and N200 latency recorded from Fz were significantly longer in the PD-MCI group than in the PD-Normal and the control group (respectively p < 0.001, p = 0.041). P300 amplitude recorded from Fz was significantly lower in PD-MCI group than those in the other groups (p = 0.038). While P300 was obtained in all patients in the PD-Normal and the control group, it was lost in 35% of PD-MCI patients. The results show that P300 provides a diagnostic tool for detecting PDMCI. We suggest that P300 prolongation and loss of P300 potential could be used as supportive parameter in the diagnosis of PD-MCI.